Two Sigma Investments has taken a short position of 0.53 percent in research company Oncopeptider and is thereby a new public short seller. This is shown by the Swedish Financial Supervisory Authority’s short-selling register.
There are two public short sellers in the company. In total, 2.32 percent of the capital is shorted.
The Swedish Financial Supervisory Authority requires positions above 0.1 percent to be reported, and short positions above 0.5 percent to be made public.
